Про Starton therapeutics

Про компанію

Starton Therapeutics is a biotechnology company focused on transforming the standard of care therapeutics. The company develops a transdermal patch technology created to transform chemotherapy-induced nausea and vomiting. It uses proven transdermal technology with proprietary drivers to obtain new indications or develop on-label superiority for patients with hematological malignancies. Starton Therapeutics was established in 2017 and is headquartered in New York.